217 related articles for article (PubMed ID: 33530281)
1. Prognostic significance of ANO1 expression in cancers.
Zhang C; Li H; Gao J; Cui X; Yang S; Liu Z
Medicine (Baltimore); 2021 Jan; 100(4):e24525. PubMed ID: 33530281
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide copy number variation analysis identified ANO1 as a novel oncogene and prognostic biomarker in esophageal squamous cell cancer.
Yu Y; Cao J; Wu W; Zhu Q; Tang Y; Zhu C; Dai J; Li Z; Wang J; Xue L; Zhen F; Liu J; Huang C; Zhao F; Zhou Y; Wen W; Pan X; Wei H; Zhu Y; He Y; Que J; Wang W; Luo J; Xu J; Chen L
Carcinogenesis; 2019 Oct; 40(10):1198-1208. PubMed ID: 31050728
[TBL] [Abstract][Full Text] [Related]
3. High ANO1 expression is a prognostic factor and correlated with an immunosuppressive tumor microenvironment in pancreatic cancer.
Zhang G; Shu Z; Yu J; Li J; Yi P; Wu B; Deng D; Yan S; Li Y; Ren D; Hou Y; Lan C
Front Immunol; 2024; 15():1341209. PubMed ID: 38352864
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of Anoctamin-1 gene at 11q13 in the development and progression of head and neck squamous cell carcinomas.
Rodrigo JP; Menéndez ST; Hermida-Prado F; Álvarez-Teijeiro S; Villaronga MÁ; Alonso-Durán L; Vallina A; Martínez-Camblor P; Astudillo A; Suárez C; María García-Pedrero J
Sci Rep; 2015 Oct; 5():15698. PubMed ID: 26498851
[TBL] [Abstract][Full Text] [Related]
5. The Mechanistic Role of the Calcium-Activated Chloride Channel ANO1 in Tumor Growth and Signaling.
Bill A; Alex Gaither L
Adv Exp Med Biol; 2017; 966():1-14. PubMed ID: 28293832
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA‑144 suppresses aggressive phenotypes of tumor cells by targeting ANO1 in colorectal cancer.
Jiang Y; Cai Y; Shao W; Li F; Guan Z; Zhou Y; Tang C; Feng S
Oncol Rep; 2019 Apr; 41(4):2361-2370. PubMed ID: 30816505
[TBL] [Abstract][Full Text] [Related]
7. Expression of anoctamin 1 is associated with advanced tumor stage in patients with non-small cell lung cancer and predicts recurrence after surgery.
He Y; Li H; Chen Y; Li P; Gao L; Zheng Y; Sun Y; Chen J; Qian X
Clin Transl Oncol; 2017 Sep; 19(9):1091-1098. PubMed ID: 28299581
[TBL] [Abstract][Full Text] [Related]
8. Prognostic and clinicopathological significance of MicroRNA-153 in human cancers: A meta-analysis.
Huang M; Li C; Kong F; Wu Y; Yuan Q; Hu L
Medicine (Baltimore); 2020 Nov; 99(46):e22833. PubMed ID: 33181653
[TBL] [Abstract][Full Text] [Related]
9. Enhanced expression of ANO1 in head and neck squamous cell carcinoma causes cell migration and correlates with poor prognosis.
Ruiz C; Martins JR; Rudin F; Schneider S; Dietsche T; Fischer CA; Tornillo L; Terracciano LM; Schreiber R; Bubendorf L; Kunzelmann K
PLoS One; 2012; 7(8):e43265. PubMed ID: 22912841
[TBL] [Abstract][Full Text] [Related]
10. Involvement of TMEM16A/ANO1 upregulation in the oncogenesis of colorectal cancer.
Yan Y; Ding X; Han C; Gao J; Liu Z; Liu Y; Wang K
Biochim Biophys Acta Mol Basis Dis; 2022 Jun; 1868(6):166370. PubMed ID: 35231545
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of miR-9 promotes epithelial mesenchymal transition via regulating anoctamin-1 (ANO1) in CRC cells.
Park YR; Lee ST; Kim SL; Zhu SM; Lee MR; Kim SH; Kim IH; Lee SO; Seo SY; Kim SW
Cancer Genet; 2019 Feb; 231-232():22-31. PubMed ID: 30803553
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Ca
Liu Z; Zhang S; Hou F; Zhang C; Gao J; Wang K
Int J Cancer; 2019 May; 144(9):2215-2226. PubMed ID: 30243029
[TBL] [Abstract][Full Text] [Related]
13. Role of ANO1 in tumors and tumor immunity.
Li H; Yu Z; Wang H; Wang N; Sun X; Yang S; Hua X; Liu Z
J Cancer Res Clin Oncol; 2022 Aug; 148(8):2045-2068. PubMed ID: 35471604
[TBL] [Abstract][Full Text] [Related]
14. Novel ANO1 Inhibitor from
Seo Y; Anh NH; Heo Y; Park SH; Kiem PV; Lee Y; Yen DTH; Jo S; Jeon D; Tai BH; Nam NH; Minh CV; Kim SH; Nhiem NX; Namkung W
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899792
[TBL] [Abstract][Full Text] [Related]
15. Calcium-activated chloride channel ANO1 promotes breast cancer progression by activating EGFR and CAMK signaling.
Britschgi A; Bill A; Brinkhaus H; Rothwell C; Clay I; Duss S; Rebhan M; Raman P; Guy CT; Wetzel K; George E; Popa MO; Lilley S; Choudhury H; Gosling M; Wang L; Fitzgerald S; Borawski J; Baffoe J; Labow M; Gaither LA; Bentires-Alj M
Proc Natl Acad Sci U S A; 2013 Mar; 110(11):E1026-34. PubMed ID: 23431153
[TBL] [Abstract][Full Text] [Related]
16. Suppression of 14-3-3γ-mediated surface expression of ANO1 inhibits cancer progression of glioblastoma cells.
Lee YS; Lee JK; Bae Y; Lee BS; Kim E; Cho CH; Ryoo K; Yoo J; Kim CH; Yi GS; Lee SG; Lee CJ; Kang SS; Hwang EM; Park JY
Sci Rep; 2016 May; 6():26413. PubMed ID: 27212225
[TBL] [Abstract][Full Text] [Related]
17. ANO1 protein as a potential biomarker for esophageal cancer prognosis and precancerous lesion development prediction.
Shang L; Hao JJ; Zhao XK; He JZ; Shi ZZ; Liu HJ; Wu LF; Jiang YY; Shi F; Yang H; Zhang Y; Liu YZ; Zhang TT; Xu X; Cai Y; Jia XM; Li M; Zhan QM; Li EM; Wang LD; Wei WQ; Wang MR
Oncotarget; 2016 Apr; 7(17):24374-82. PubMed ID: 27016410
[TBL] [Abstract][Full Text] [Related]
18. Cinobufagin Exerts Anticancer Activity in Oral Squamous Cell Carcinoma Cells through Downregulation of ANO1.
Jo S; Yang E; Lee Y; Jeon D; Namkung W
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769467
[TBL] [Abstract][Full Text] [Related]
19. Ano1/TMEM16A Overexpression Is Associated with Good Prognosis in PR-Positive or HER2-Negative Breast Cancer Patients following Tamoxifen Treatment.
Wu H; Guan S; Sun M; Yu Z; Zhao L; He M; Zhao H; Yao W; Wang E; Jin F; Xiao Q; Wei M
PLoS One; 2015; 10(5):e0126128. PubMed ID: 25961581
[TBL] [Abstract][Full Text] [Related]
20. LXR Signaling-Mediated Cholesterol Metabolism Reprogramming Regulates Cancer Cell Metastasis.
Singh PK; Mehla K
Cancer Res; 2023 Jun; 83(11):1759-1761. PubMed ID: 37264829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
